Stereotaxis to Report Second Quarter 2018 Financial Results on August 7, 2018
Jul. 31, 2018
ST. LOUIS, July 31, 2018 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (OTCQX:STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will release financial results for its 2018 second quarter ended June 30, 2018 on Tuesday, August 7, 2018 before the open of the U.S. financial markets. The Company will host a conference call and webcast at 10:00 a.m. Eastern Time that day to discuss the Company’s results and corporate developments.
What: Stereotaxis second quarter 2018 financial results conference call When: Tuesday, August 7th at 10:00 a.m. Eastern Time (7:00 a.m. PT) Dial In Number: To access the live call, dial 855-719-5012 (US and Canada) or 334-323-0522 (International) and give the participant pass code 1337116. Webcast: To access the live and replay webcast, please visit the investor relations section of Stereotaxis’ website at www.stereotaxis.com. A phone replay of the call will be available for one week beginning approximately two hours Call Replay: following the end of the call through Tuesday, August 14, 2018. To access the replay dial-in information, please click here.
About StereotaxisStereotaxis is the global leader in innovative robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. Over 100 issued patents support the Stereotaxis platform. The core components of Stereotaxis’ systems have received regulatory clearance in the United States, European Union, Japan, Canada, China, and elsewhere. For more information, please visit www.stereotaxis.com.
Company Contacts: David L. FischelChairman and Chief Executive Officer
Martin C. StammerChief Financial Officer